Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis
An observational study in Canadian patients aged 6 years and older examines outcomes of Dupixent (dupilumab) for moderate to severe atopic d…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Drug Survival of Target Therapies in Atopic Dermatitis
A clinical trial is currently recruiting to assess drug survival (durability of use) of targeted therapies in atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis [Phase 4]
Phase 4 clinical trial in Atopic Dermatitis was terminated, with results posted showing improvements in scratch behavior and sleep.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study [Phase 4]
Phase 4 pilot trial evaluating whether Vitamin D can help treat moderate to severe atopic dermatitis in young children; the study has been t…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)
ODIN is a completed clinical trial evaluating the use of LC-OCT to diagnose inflammatory dermatoses, assessing its potential diagnostic valu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis [Phase 2]
Phase 2 study of QLM3003 Ointment in participants with mild-to-moderate atopic dermatitis has completed. The available snippet notes complet…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® [Phase 1]
Phase 1 pharmacokinetic study comparing QL2108 to Dupixent (dupilumab) in individuals with atopic dermatitis; the trial status is completed.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Therapist-guided vs Self-guided CBT for AD: Non-inferiority Trial [NA]
Karolinska Institutet completed a non-inferiority clinical trial comparing therapist-guided versus self-guided cognitive-behavioral therapy …
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of orismilast in atopic dermatitis has completed, with results posted on 2025-03-07.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis [Phase 2]
Phase 2 safety and efficacy study of EVO101 topical cream in Atopic Dermatitis has completed and results have been posted. Sponsor: Evommune…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis [Phase 1, Phase 2]
The update reports the completion of Phase 1 and Phase 2 studies evaluating the safety, pharmacokinetics, and efficacy of AK120 in subjects …
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
An observational real-world study to assess changes in disease activity and use of Upadacitinib tablets in adolescent and adult participants…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Herbal Ointment in Treating Atopic Dermatitis Topically [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating a herbal ointment for topical treatment of atopic dermatitis and is currently recruiting.
-
FDA approval · 2025-02-26FDA Approved: FLUOCINONIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved fluocinonide from Quagen Pharmaceuticals LLC under an Original Application (ANDA 216389). This is a generic topical corticoster…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 study evaluating AK120 for moderate-to-severe atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis [Phase 1]
Phase 1 safety, tolerability and pharmacokinetic study of LEO 29102 in subjects with atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis [Phase 1]
Phase 1 safety and tolerability evaluation of LEO 138559 in healthy subjects and participants with Atopic dermatitis. The study is completed…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 [Phase 1]
This update announces the completion of a Phase 1 drug-drug interaction trial evaluating tralokinumab in patients with moderate to severe at…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) [Phase 1]
Clinical trial update reporting completion of a Phase 1 study of LEO 39652 Cream in adults with mild-to-moderate atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: LEO 29102 Single and Multiple Dose Study by Dermal Application [Phase 1]
Phase 1 study of LEO 29102 for atopic dermatitis, evaluating single and multiple dermal doses, has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 [Phase 1]
Phase 1 safety, tolerability and pharmacokinetic study of dermal application of LEO 29102 in healthy subjects. The study targets Atopic Derm…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream [Phase 1]
This Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of cutaneous LEO 39652 Cream in adults with Atopic Dermatitis an…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects [Phase 1]
Phase 1 trial evaluating pharmacokinetics, immunogenicity, safety, and tolerability of LEO 138559 in healthy Japanese subjects has completed…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the safety and efficacy of a topical scalp treatment for seborrheic dermatitis and related dry-sk…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of LEO 29102 Cream in atopic dermatitis; the trial was terminated.